Filter Results:
(104)
Show Results For
- All HBS Web (139)
- Faculty Publications (32)
Show Results For
- All HBS Web (139)
- Faculty Publications (32)
Sort by
- 31 Jan 2017
- First Look
First Look at New Research: January 31, 2017
Abstract—The Food and Drug Administration approves new medical devices after in-depth reviews of safety and effectiveness data. Some have advocated for shorter review times to encourage innovation. We evaluated whether regulatory review... View Details
Keywords: Carmen Nobel
- 04 Aug 2009
- First Look
First Look: August 4
extant GAAP, as observed in a regulated setting, with GAAP that might arise endogenously as a result of market forces. Building on previous research, we argue that verifiability and conservatism, while detracting from accounting's role in... View Details
Keywords: Martha Lagace
- 25 Sep 2018
- First Look
New Research and Ideas, September 25, 2018
operations. Product failures are, therefore, likely to impact firms’ subsequent innovation activities. Using 13 years of Food and Drug Administration data, we examine the effects of firm and competitor medical device recalls on subsequent... View Details
Keywords: Dina Gerdeman
- 08 Nov 2016
- First Look
November 8, 2016
use standardized color, achieved by synthetic dyes, as part of their marketing strategies. Food manufacturers along with dye makers and regulators co-created the food-coloring business. Synthetic food dyes provided the food manufacturers... View Details
Keywords: Sean Silverthorne
- 22 May 2020
- In Practice
Post-COVID Health Care: More Screens, Less Red Tape?
Fetter, a senior lecturer, is former CEO of Tenet Healthcare. Regulations that limit care might be loosened Richard Hamermesh: Cutting the red tape in diagnostic testing The crisis has revealed the weakest part of our medical system—the... View Details
Keywords: by Danielle Kost
- 04 Jun 2007
- Research & Ideas
Is Health Care Making You Better—or Dead?
mother gave me a copy of The Jungle by Upton Sinclair. I was very struck by that book. I find the writing, in retrospect, really wretched, but the kind of passion that said, "Here is an awful system," was pivotal in getting food and View Details
- 22 Apr 2008
- First Look
First Look: April 22, 2008
Business Harvard Business School Case 608-136 Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in... View Details
Keywords: Martha Lagace
- 12 May 2008
- Research & Ideas
Accounting Information as Political Currency
developed and fast-developing nations. Data on legislative-election vote shares are also likely available for many jurisdictions. The data on cash contributions from companies to politicians will be tricky—the United States has relatively better disclosure View Details
Keywords: by Martha Lagace
- 30 Jun 2020
- Book
Capitalism Is More at Risk Than Ever
capitalism powered by private enterprise and appropriately regulated offers the best hope for continuing to improve living standards and the well-being of people across the world. Lagace: What’s an example or two of businesses that are... View Details
Keywords: by Martha Lagace
- 03 Jan 2017
- First Look
January 3, 2017
to standardize their products and helped establish brand identities through consistent appearance. By 1938, food dyes had achieved such widespread use, and had raised such public concern, that the federal government amended the 1906 Pure Food and View Details
Keywords: Carmen Nobel
- 14 Apr 2021
- Research & Ideas
The High Cost of the Slow COVID Vaccine Rollout
the United States, the Federal Drug Administration this week advised states to pause the use of the Johnson & Johnson vaccine after six women developed a rare blood-clotting disorder, raising new concerns about total vaccine supply.... View Details
- 30 Oct 2007
- First Look
First Look: October 30, 2007
Changing Context of Pharmaceutical Risk Mitigation Author:Arthur A. Daemmrich Periodical:Pharmacy in History 49, no. 2 (2007): 61-75 Abstract In the wake of Vioxx, Avandia, and other recent prominent cases of drugs found to cause side... View Details
Keywords: Sean Silverthorne
- 25 Feb 2014
- First Look
First Look: February 25
in the country's economy during the past two decades, have brought together a group of economists and political scientists to systematically examine the impact of a wide range of factors affecting the economy's collapse, from the cost of labor View Details
Keywords: Sean Silverthorne
- 17 Oct 2006
- First Look
First Look: October 17, 2006
find support for these hypotheses. Download working paper: http://www.hbs.edu/research/pdf/07-022.pdf Resolving Information Asymmetries in Markets: The Role of Certified Management Programs Author: Michael W. Toffel Abstract Firms and View Details
Keywords: Sean Silverthorne
- 13 Jan 2009
- First Look
First Look: January 13, 2009
and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical testing takes between five and seven... View Details
Keywords: Martha Lagace
- 15 Apr 2014
- First Look
First Look: April 15
from the U.S. Food and Drug Administration (FDA) ordering the company to halt the sale and promotion of its genetic testing kit. The FDA stated that the product was marketed as a diagnostic and preventative tool and that it was subject to... View Details
Keywords: Sean Silverthorne
- 01 May 2007
- First Look
First Look: May 1, 2007
(along with personal relations), laws and regulations can evolve to facilitate real estate investments. Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=207090 The Convention on Biological Diversity:... View Details
Keywords: Sean Silverthorne
- 22 Aug 2006
- First Look
First Look: August 22, 2006
805-067 Molecular Insight has developed a novel biopharmaceutical to detect heart attacks. The company's unique approach to intellectual property protection uses the Hatch Waxman Act and the Orphan Drug Act. The company is struggling to... View Details
Keywords: Martha Lagace
- 01 Jul 2008
- First Look
First Look: July 1, 2008
establish a proposed alliance with a pharmaceutical firm? Should it create a nutraceuticals business in parallel to its effort to develop anti-aging therapeutics? And, should it in-license a second drug development candidate? Purchase... View Details
Keywords: Martha Lagace
- 21 Apr 2009
- First Look
First Look: April 21, 2009
Industry Location Author:Arthur A. Daemmrich Abstract A consumer-oriented model for drug development and use has attracted attention in recent years as an alternative to the much-maligned approach of mass-marketing blockbuster drugs. In a... View Details
Keywords: Martha Lagace